Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 1/20 | 0.63 |
| ▸ | FNTB | P49356 | 1/20 | 0.63 |
| ▸ | MAOB | P27338 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 9/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14011737 | 0.88 | FNTA (0.79) | FNTAFNTBMAOBMAPTALDH1A1 | |
| SCHEMBL22611887 | 0.88 | FNTA (0.79) | FNTAFNTBMAOBMAPTALDH1A1 | |
| SCHEMBL12416775 | 0.83 | FNTA (0.76) | FNTAFNTBMAOBMAPTALDH1A1 | |
| SCHEMBL22624802 | 0.82 | FNTA (0.46) | FNTAFNTBMAOBMAPTALDH1A1 | |
| SCHEMBL12416649 | 0.82 | SIRT2 (0.69) | FNTAFNTBMAOBMAPTALDH1A1 | |
| SCHEMBL22624809 | 0.81 | FNTA (0.76) | FNTAFNTBMAOBMAPTALDH1A1 | |
| SCHEMBL22624804 | 0.79 | FNTA (0.65) | FNTAFNTBMAOBMAPTALDH1A1 | |
| SCHEMBL6742179 | 0.78 | GPR35 (0.51) | MAPTALDH1A1KDM4ELMNAGAA | |
| SCHEMBL6742183 | 0.77 | MAPT (0.56) | MAPTALDH1A1KDM4ELMNAGAA | |
| SCHEMBL1027159 | 0.77 | MAPT (0.46) | FNTAFNTBMAOBMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2614091-B1 | CATALYST FOR POLYMERIZING NORBORNENE MONOMERS AND A METHOD FOR PRODUCING NORBORNENE POLYMER | SHOWA DENKO KK (JP) | 2016-04-20 | — | — | EP | disclosed |
| US-20130059993-A1 | CATALYST FOR POLYMERIZATION OF NORBORNENE MONOMERS, METHOD FOR PRODUCING NORBORNENE POLYMER, METHOD FOR PRODUCING NORBORNENE COPOLYMER, NORBORNENE POLYMER AND TRANSITION METAL COMPLEX | SHOWA DENKO K.K. (JP) | 2013-03-07 | — | — | US | disclosed |
| US-20130059993-A1 | CATALYST FOR POLYMERIZATION OF NORBORNENE MONOMERS, METHOD FOR PRODUCING NORBORNENE POLYMER, METHOD FOR PRODUCING NORBORNENE COPOLYMER, NORBORNENE POLYMER AND TRANSITION METAL COMPLEX | SHOWA DENKO K.K. (JP) | 2013-03-07 | — | — | US | disclosed |
| WO-2012033227-A2 | CATALYST FOR POLYMERIZING NORBORNENE MONOMERS AND A METHOD FOR PRODUCING NORBORNENE POLYMER | SHOWA DENKO K.K. (JP) | 2012-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130059993-A1 | CATALYST FOR POLYMERIZATION OF NORBORNENE MONOMERS, METHOD FOR PRODUCING NORBORNENE POLYMER, METHOD FOR PRODUCING NORBORNENE COPOLYMER, NORBORNENE POLYMER AND TRANSITION METAL COMPLEX | NNMT, PPOX, DNMT1 | FNTA 1034/4885FNTB 992/4885MAOB 886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.